United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol - solution for injection - 200mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol - solution for injection - 700mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - ethanol - solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - ethanol - solution for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol - solution for injection - 900mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol 90% - solution for injection - 900mg/1gram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol - cutaneous solution - 200ml/1litre

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol - solution for injection - .5ml/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - ethanol - eye drops - 180ml/1litre

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - ceftriaxone sodium (unii: 023z5br09k) (ceftriaxone - unii:75j73v1629) - ceftriaxone 10 g - before instituting treatment with ceftriaxone for injection usp, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. therapy may be instituted prior to obtaining results of susceptibility testing. to reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection usp and other antibacterial drugs, ceftriaxone for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. ceftriaxone for injection usp is indicated for the treatment of the following infections when caused by susceptible organisms: lower respiratory tract infections caused by s